Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Christof J. Majoor (Baarn, Netherlands), Christof Majoor, Marlous Sneeboer, Anne De Kievit, Joost Meijers, Tom Van der Poll, Rene Lutter, Pieter Willem Kamphuisen, Elisabeth Bel. Effect of a 10-day oral corticosteroid course on hemostasis and inflammation in patients with stable asthma. Eur Respir J 2015; 46: Suppl. 59, 1002

Member's Comments

No comment yet.

Related content which might interest you: Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Oral and inhaled corticosteroid use has a time-dependent association with recurrent pulmonary embolism Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Eosinophilic inflammation amplifies the prednisolone-induced prothrombotic state in asthma Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma Source: International Congress 2016 – Asthma management Year: 2016 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Effect of roflumilast on airway remodeling in a murine model of chronic asthma Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry. Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics Source: International Congress 2016 – Systemic biomarkers Year: 2016 Treating peripheral eosinophilia in asthma: Simple and effective Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Poor adherence to ICS treatment in patients with chronic respiratory diseases Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Implication of IL-18 in the chronic inflammation of severe refractory asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014